Naltrexone depot - elbion

Drug Profile

Naltrexone depot - elbion

Alternative Names: Naltrel

Latest Information Update: 03 Nov 2009

Price : $50

At a glance

  • Originator DrugAbuse Sciences
  • Developer elbion NV
  • Class Analgesics; Cyclopropanes; Drug withdrawal therapies; Irritable bowel syndrome therapies; Morphinans; Small molecules
  • Mechanism of Action Opioid receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Alcoholism; Opioid abuse

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 19 Jan 2007 elbion NV acquires naltrexone depot from DrugAbuse Sciences
  • 14 Jun 2006 This compound is still in active development for alcoholism and opioid abuse
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top